Shanghai Junshi Biosciences Co., Ltd. (1877.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap19.27B
Enterprise Value20.79B
P/E Ratio-57.14
PEG Ratio-0.78
Price/Sales Ratio13.88
Price/Book Ratio6.46
Enterprise/Revenue14.64
Enterprise/EBITDA-69.88

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.24
Operating Margin-0.3
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.11

Income Statement

Revenue2.43B
Revenue/Share2.66
Gross Profit1.97B
EBITDA-599.38M
Net Income-851.76M
Diluted EPS-0.84

Balance Sheet

Total Cash4.55B
Total Cash/Share4.45
Total Debt5.96B
Total Debt/Equity1.01
Current Ratio2.14
Book Value Per Share5.94

Price History

52-Week Change-17.69
52-Week High38.64
52-Week Low15.25
Moving Average 50 Days20.32
Moving Average 200 Days23.14

Statistics

Average Volume4.18M
Shares Outstanding1.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.15
Last Split FactorN/A
Last Split DateN/A
AD